- AU$135.09m
- AU$96.64m
- AU$5.91m
Australia Stock Exchange release from DIMERIX : PRE_NR Ends: 10:01:12
Dimerix gains on ethics approval for COVID-19 study in Australia
Australia Stock Exchange release from DIMERIX : PRE_NR Ends: 09:27:28
Australia Stock Exchange release from DIMERIX : Ethics Approval in Australia for Phase 3 COVID-19 Study
Australia Stock Exchange release from DIMERIX : Dimerix Receives Further MRFF Funding for DMX-200
Australia Stock Exchange release from DIMERIX : DSMB Recommends Continuation of Ph3 COVID-19 Study in Europe
Australia Stock Exchange release from DIMERIX : PRE_NR Ends: 12:23:38
Australia Stock Exchange release from DIMERIX : Pause in Trading
Australia Stock Exchange release from DIMERIX : Notification regarding unquoted securities - DXB
Australia Stock Exchange release from DIMERIX : Investor Presentation
Australia Stock Exchange release from DIMERIX : Quarterly Appendix 4C and Activities Report
Australia Stock Exchange release from DIMERIX : PRE_NR Ends: 09:34:29
Brief: Dimerix Says First Approvals Received For Start Of Phase 3 FSGS Trial
Australia Stock Exchange release from DIMERIX : First Approvals Received for Start of Phase 3 FSGS Trial
Australia Stock Exchange release from DIMERIX : PRE_NR Ends: 08:49:00
Australia Stock Exchange release from DIMERIX : PRE_NR Ends: 10:11:35
Australia Stock Exchange release from DIMERIX : Phase 3 DMX-200 COVID-19 Study Expands into Australia
Australia Stock Exchange release from DIMERIX : Change in substantial holding
Australia Stock Exchange release from DIMERIX : Becoming a substantial holder